Trade Pluri Inc. - PLUR CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.133
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.02221 %(-$4.44)Trade size with leverage ~ $20,000.00Money from leverage ~ $19,000.00Go to platform: -0.02221%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.00002 %(-$0.00)Trade size with leverage ~ $20,000.00Money from leverage ~ $19,000.00Go to platform: -0.00002%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.02221 %
  (-$4.44)

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.00002 %
  (-$0.00)

Key Stats

• Prev. Close: 0.9487
• Open: 0.9459
• 1-Year Change: -74.41%
• Day's Range: 0.9459 - 1.1584

Trade Pluri Inc. - PLUR

What is Pluri Inc. (PLUR)?

Pluri Inc. is a biotechnology company focused on the development and commercialization of novel cell therapies. The company specializes in regenerative medicine, aiming to address unmet medical needs through innovative treatments derived from stem cells. Pluri's research and development efforts concentrate on leveraging pluripotent stem cells to create therapies for various diseases, including those affecting the lungs and other organs. The company operates within the biopharmaceutical industry, engaging in both preclinical and clinical stages of product development. Pluri collaborates with academic institutions and industry partners to advance its therapeutic candidates. Its strategic focus includes the exploration of cell-based approaches to treat conditions with limited existing treatment options, contributing to the broader field of regenerative medicine and cellular therapy.

Pluri Inc. Stock Price Today: Live Overview

The price today is shaped by current session dynamics, as Pluri Inc. stands at $1.1915. The price has varied from $0.945 to $1.0586 during the day, with a percentage change of -1.9733%.

FAQ: Pluri Inc. (PLUR)

What is the current price of PLUR stock?

The current price is $1.1915.

Does PLUR pay dividends?

Dividends are not paid by this company.

Does PLUR have a formal corporate presence or regional headquarters in the UAE?

Pluri Inc. does not have an official office or subsidiary in the UAE and operates through distributors.

What is PLUR best known for?

Pluri Inc. is most famous for its regenerative medicine technologies.

What assets are typically shown together with PLUR?

Commonly shown alongside PLUR: LivePerson Inc, Atlanta Braves Holdings Inc - C, iShares Bloomberg Enhanced Roll Yield Commodity Swap UCITS ETF